Objectives: Repeated cycles of pulmonary exacerbation of chronic infection cause tissue damage and progressive drop in lung function for CF patients so making effective treatment and prevention strategies imperative. Our study aims to better understand the response to antibiotics and identify biomarker targets suitable for improved therapeutic or preventative treatments. Methods: Multidimensional LC-MS/MS and relative quantitation was employed to investigate the changes in sputum cellular proteome following antibiotic treatment in 12 CF patients chronically infected with Pseudomonas aeruginosa. Conclusions: 1989 human proteins were identified in total. 37 proteins out of the 318 detected in >80% samples were differentially expressed (p < 0.05) after antibiotic treatment. Of these, 22 exhibited a strong correlation (r = 0.969) between their pre-antibiotic/post-antibiotic ratios and ratios for the same proteins comparing CF/healthy control cohorts, thus suggesting that successful treatment promotes a proteome shift towards a non-CF profile. Ingenuity Pathway Analysis software showed antibiotic treatment to most affect the molecular and cellular function categories of Cellular Movement (particularly Immune Cell Trafficking), Organismal Injury and Abnormalities, Cell Death and Free Radical Scavenging. 67 P. aeruginosa proteins and 17 proteins from other bacterial species were also detected. Bacterial proteins accounted for 0.5−35% of CF sputum cellular protein. Although total cellular protein (per g sputum) decreased following antibiotic treatment, the percentage attributable to bacteria did not alter and no bacterial proteins were detected as differentially expressed. Growth of Pseudomonas aeruginosa in biofilm makes it more resistant to antimicrobial treatment, and biofilm formation may reduce effectivness of the antibiotic therapy in children with cystic fibrosis (CF). Aim: To study the biofilm formation ability of P. aeruginosa isolates from CF children to optimize azithromycin (AZM) administration. Materials and Methods: Formation of biofilms was studied by determination the ability of 12 P. aeruginosa strains (6 mucoid and 6 non mucoid isolates) to adhesion on the surface of 96-well polystyrol plate. Isolates were incubated in broth for 2 days at 36.8ºC, diluted 1/100 and inoculated in a 96-well polystyrol plate (8 replicates for each isolate, in 4 replicates 5 mg/mL AZM was added). Biofilms were grown for 2 days at 36.8ºC in humid container, then planktonic cells were removed. Biofilms were stained by 0.1% crystal violet, washed 3 times with distilled water. To estimate biofilm formation, after 96% ethanol addition optical density (wave length 540 nm) was measured by a plate-reader. Results: Ability to biofilm formation was identified in 10 out of 12 isolates (83%), 2 isolates did not form biofilm. AZM suppressed biofilm development in 7 of 10 isolates decreasing biofilm density by 1.7−4.2 times. Suppression of biofilm formation by other isolates was not significant.
Growth of Pseudomonas aeruginosa in biofilm makes it more resistant to antimicrobial treatment, and biofilm formation may reduce effectivness of the antibiotic therapy in children with cystic fibrosis (CF). Aim: To study the biofilm formation ability of P. aeruginosa isolates from CF children to optimize azithromycin (AZM) administration. Materials and Methods: Formation of biofilms was studied by determination the ability of 12 P. aeruginosa strains (6 mucoid and 6 non mucoid isolates) to adhesion on the surface of 96-well polystyrol plate. Isolates were incubated in broth for 2 days at 36.8ºC, diluted 1/100 and inoculated in a 96-well polystyrol plate (8 replicates for each isolate, in 4 replicates 5 mg/mL AZM was added). Biofilms were grown for 2 days at 36.8ºC in humid container, then planktonic cells were removed. Biofilms were stained by 0.1% crystal violet, washed 3 times with distilled water. To estimate biofilm formation, after 96% ethanol addition optical density (wave length 540 nm) was measured by a plate-reader. Results: Ability to biofilm formation was identified in 10 out of 12 isolates (83%), 2 isolates did not form biofilm. AZM suppressed biofilm development in 7 of 10 isolates decreasing biofilm density by 1.7−4.2 times. Suppression of biofilm formation by other isolates was not significant. Conclusion: In most cases, P. aeruginosa isolates from CF children were able to form biofilm. Suppression of biofilm formation in 2/3 of examined P. aeruginosa isolates induced by AZM confirms the need of further research in this field to optimize macrolide antibiotics administration. (Table) . PA isolates were more susceptible than BURK isolates to all antibiotics. 
